Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Stuckey

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
European Heart Journal|June 9, 2007
Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarctionPaul Sorajja, Bernard J Gersh, David A Cox, et al.
The American Journal of Cardiology|October 13, 2004
Predictors of and outcomes of early thrombosis following balloon angioplasty versus primary stenting in acute myocardial infarction and usefulness of abciximab (the CADILLAC trial)George Dangas, Eve D Aymong, Roxana Mehran, et al.
Journal of the American College of Cardiology|April 3, 2010
Impact of delay to angioplasty in patients with acute coronary syndromes undergoing invasive management: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trialPaul Sorajja, Bernard J Gersh, David A Cox, et al.
The New England Journal of Medicine|March 29, 2002
Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarctionGregg W Stone, Cindy L Grines, David A Cox, et al.
American Heart Journal|December 22, 2005
Impact of body mass index on outcomes after primary angioplasty in acute myocardial infarctionEugenia Nikolsky, Gregg W Stone, Cindy L Grines, et al.
JACC. Cardiovascular Interventions|May 26, 2009
Outcomes and complications with off-label use of drug-eluting stents: results from the STENT (Strategic Transcatheter Evaluation of New Therapies) groupBruce R Brodie, Thomas Stuckey, William Downey, et al.
Journal of Thrombosis and Thrombolysis|September 28, 2010
Bleeding events are associated with an increase in markers of inflammation in acute coronary syndromes: an ACUITY trial substudyCharles L Campbell, Steven R Steinhubl, William C Hooper, et al.
The American Journal of Cardiology|October 30, 2003
Outcomes following bail-out abciximab administration during primary intervention in acute myocardial infarction (The CADILLAC Trial)Dale T Ashby, Eve A Aymong, James E Tcheng, et al.
The American Journal of Cardiology|October 13, 2004
Influence of admission and discharge aspirin use on survival after primary coronary angioplasty for acute myocardial infarctionDavid E Kandzari, James E Tcheng, Cindy L Grines, et al.
Journal of the American College of Cardiology|July 24, 2010
When is door-to-balloon time critical? Analysis from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) and CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trialsBruce R Brodie, Bernard J Gersh, Thomas Stuckey, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
European Heart Journal|June 9, 2007
Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarctionPaul Sorajja, Bernard J Gersh, David A Cox, et al.
The American Journal of Cardiology|October 13, 2004
Predictors of and outcomes of early thrombosis following balloon angioplasty versus primary stenting in acute myocardial infarction and usefulness of abciximab (the CADILLAC trial)George Dangas, Eve D Aymong, Roxana Mehran, et al.
Journal of the American College of Cardiology|April 3, 2010
Impact of delay to angioplasty in patients with acute coronary syndromes undergoing invasive management: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trialPaul Sorajja, Bernard J Gersh, David A Cox, et al.
The New England Journal of Medicine|March 29, 2002
Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarctionGregg W Stone, Cindy L Grines, David A Cox, et al.
American Heart Journal|December 22, 2005
Impact of body mass index on outcomes after primary angioplasty in acute myocardial infarctionEugenia Nikolsky, Gregg W Stone, Cindy L Grines, et al.
JACC. Cardiovascular Interventions|May 26, 2009
Outcomes and complications with off-label use of drug-eluting stents: results from the STENT (Strategic Transcatheter Evaluation of New Therapies) groupBruce R Brodie, Thomas Stuckey, William Downey, et al.
Journal of Thrombosis and Thrombolysis|September 28, 2010
Bleeding events are associated with an increase in markers of inflammation in acute coronary syndromes: an ACUITY trial substudyCharles L Campbell, Steven R Steinhubl, William C Hooper, et al.
The American Journal of Cardiology|October 30, 2003
Outcomes following bail-out abciximab administration during primary intervention in acute myocardial infarction (The CADILLAC Trial)Dale T Ashby, Eve A Aymong, James E Tcheng, et al.
The American Journal of Cardiology|October 13, 2004
Influence of admission and discharge aspirin use on survival after primary coronary angioplasty for acute myocardial infarctionDavid E Kandzari, James E Tcheng, Cindy L Grines, et al.
Journal of the American College of Cardiology|July 24, 2010
When is door-to-balloon time critical? Analysis from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) and CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trialsBruce R Brodie, Bernard J Gersh, Thomas Stuckey, et al.
Pageof 5